Aspen Aerogels, Inc. · NYSE:ASPN
Aspen Aerogels — Q2 2022 Earnings Presentation
13 slides from Aspen Aerogels's earnings presentation, Jul 28, 2022
Slide 1: Aspen Aerogels Q2 2022 Financial Results Call
July 28, 2022 ASPEN AEROGELS Q 2 2 0 2 2 F I N A N C I A L R E S U LT S C A L L
Slide 2: Disclaimer on Forward Looking Statements
Disclaimer on Forward Looking Statements This presentation contains statements that constitute “forward‐looking statements” under the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “believe,” “could,” “estimate,” “expect,” “guidance,” “intend,” “may,” “plan,” “potential,”
Slide 3: Disclaimer on Forward Looking Statements
Disclaimer on Forward Looking Statements The presentation contains information regarding certain financial targets with respect to the Company. Such financial targets constitutes forward looking information and is for illustrative purposes only and should not be relied upon as necessarily being indi
Slide 4: Recent Financing Activities and Q2 Developments
Recent Financing Activities and Q2 Developments Advancing a plan designed to turn Aspen Aerogels into a potential $1.6B revenue and $400M adjusted EBITDA business Recent Financing Activities Q2 and Recent Highlights • $312M raised since January of 2021 • 44% YoY Revenue Growth • 19% QoQ Revenue Grow
Slide 5: Q2 2022 Financial Highlights
Q2 2022 Financial Highlights 44% YoY revenue growth driven by strong demand across all markets and higher than expected thermal barrier volumes $ in millions except per share figures Q2 2021 Q2 20221 H1 2021 H1 20221 2022 Outlook1 Commentary Continued PyroThin ® volume growth REVENUES $31.7 $45.6 $5
Slide 6: Operating Plan to Drive Down the Cost of Sales
Operating Plan to Drive Down the Cost of Sales Managing capacity transitions and expansion across both segments enables the path to our target gross margins EV Thermal Barriers Energy Industrial • Move to Mexico with • Automation • Enabling non- • Product portfolio • Plant II online • Chemical formu
Slide 7: OEMs' Increasing Cell-to-Cell Barrier Adoption
OEMs’ Increasing Cell-to-Cell Barrier Adoption 7 of the top 8 EV OEMs use compatible cell form factors and can add cell-to-cell barriers to enhance safety Passive Thermal Runaway Solutions 3 Market Position 1 Battery Strategy 2 More Protection 2021 Global 2025 Global Cell Cell Form Cooling Pack Modu
Slide 8: Relevant Regulatory Landscape Developments
Relevant Regulatory Landscape Developments Warning of thermal propagation and runaway is a key part of emerging global EV safety and testing standards EMERGING REGULATIONS AND TESTING ARE DRIVING COUNTRY LEVEL STANDARDS STANDARDS AIMED AT EV SAFETY… FOR THERMAL PROPAGATION Country Level Implementati
Slide 9: EV Thermal Barrier Commercial Progress
EV Thermal Barrier Commercial Progress Aspen has been awarded business, is quoting, or in discussions with several OEMs that it believes will drive EV production 2025 Forecasted EV Production Volume (M units) and Sourcing Status by OEM Group HQ Location 1 North America Western Europe Asia TAM 8.7 TA
Slide 10: Our Strategy to Create Stakeholder Value
Our Strategy to Create Stakeholder Value Leveraging our platform in markets with favorable dynamics while focusing on doing the right things well creates value WHO WE ARE WHAT WE DO CREATES VALUE PROPRIETARY AEROGEL TM OPTIMIZE AND EXPAND OUR PLATFORM Peers’ 1 Revenue Growth / EBITDA Margins 2 side
Slide 11: Appendix
Appendix GAAP-Non-GAAP Reconciliation
Slide 12: GAAP to Non-GAAP Reconciliation
GAAP to Non-GAAP Reconciliation Q2 Q2 YTD FY 2022 ($ in thousands) 2022 2021 2022 2021 Low High Net loss (24,050) (6,669) (43,534) (12,919) (86,800) (79,800) Depreciation and Amortization 2,032 2,104 4,161 4,742 9,700 9,700 Stock-based Compensation 2,295 1,070 4,123 2,046 8,300 8,300 Interest Expens
Slide 13: - ASPEN|acrogels
- ASPEN|acrogels